Edwards Lifesciences Corporation (EW) Shareholders & Insider Trades
Edwards Lifesciences shareholders at a glance
The largest holder of Edwards Lifesciences stock is BlackRock Advisors LLC, with 42.3 million shares (7.33% of the company), worth about $3.83 billion as of September 25, 2026. The 10 largest holders together own 40.7%.
In Q2 2026, 1,387 institutional holdings reports listed shares worth $48.20 billion.
Insiders reported 100 transactions in the last two years: 30 sales worth $21.10 million and no purchases. The newest one on file is from May 12, 2026 (Zovighian Bernard J, Chief Executive Officer).
Major holders as of September 25, 2026; quarterly totals from institutional holdings reports (latest Q2 2026); insider transactions on file through May 12, 2026.
Edwards Lifesciences Corporation
Shareholders Summary
2026Q2
Ownership by Type
Geographic Distribution
Largest Edwards Lifesciences shareholders
| Holder | Shares | % of company | Value |
|---|---|---|---|
| BlackRock Advisors LLC | 42.3 million | 7.33% | $3.8B |
| Vanguard Capital Management LLC | 37.6 million | 6.53% | $3.4B |
| Vanguard Portfolio Management LLC | 26.4 million | 4.58% | $2.4B |
| State Street Corporation | 26.3 million | 4.57% | $2.4B |
| JPMorgan Investment Management, Inc. | 22.8 million | 3.95% | $2.1B |
| Union Investment Institutional GmbH | 18.3 million | 3.18% | $1.7B |
| Wellington Trust Co., NA | 16.8 million | 2.92% | $1.5B |
| Geode Capital Management LLC | 15.4 million | 2.68% | $1.4B |
| BlackRock Life Ltd. | 14.6 million | 2.53% | $1.3B |
| BNY Mellon Investment Adviser, Inc. | 14.1 million | 2.44% | $1.3B |
As of September 25, 2026.
Edwards Lifesciences institutional holdings by quarter
| Quarter | Reports | Shares | Value |
|---|---|---|---|
| Q2 2026 | 1,387 | – | $48.2B |
| Q1 2026 | 1,351 | 504.0 million | $40.4B |
| Q4 2025 | 1,379 | 507.0 million | $43.2B |
| Q3 2025 | 1,335 | 525.0 million | $40.8B |
| Q2 2025 | 1,327 | 506.0 million | $39.5B |
| Q1 2025 | 1,275 | 506.0 million | $36.7B |
| Q4 2024 | 1,307 | 503.0 million | $37.2B |
| Q3 2024 | 1,284 | 492.0 million | $32.4B |
Shares and value held by institutions that file quarterly holdings reports (options not included).
Edwards Lifesciences insider trades
| Insider | Date | Title | Transaction | Value |
|---|---|---|---|---|
| Zovighian Bernard J | May 12, 2026 | Chief Executive Officer | Stock Gift at price 0.00 per share. | – |
| Zovighian Bernard J | May 12, 2026 | Chief Executive Officer | Sale at price 77.92 - 78.40 per share. | $2.8M |
| Chopra Daveen | May 11, 2026 | Officer | -- | – |
| Zovighian Bernard J | May 11, 2026 | Chief Executive Officer | -- | – |
| Ullem Scott B | May 11, 2026 | Chief Financial Officer | -- | – |
| Bobo Donald E Jr | May 11, 2026 | Officer | -- | – |
| Zovighian Bernard J | May 11, 2026 | Chief Executive Officer | Stock Gift at price 0.00 per share. | – |
| Markowitz Wayne | May 11, 2026 | Officer | Sale at price 79.73 per share. | $47,280 |
| Feinberg David T | May 8, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Laviolette Paul A | May 8, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Loranger Steven R | May 8, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Gallahue Kieran T. | May 8, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
Newest 12 of 100 insider transactions in the last two years.
Questions and answers
Who owns the most Edwards Lifesciences stock?
BlackRock Advisors LLC, with 7.33% of the company (as of September 25, 2026). Next: Vanguard Capital Management LLC (6.53%) and Vanguard Portfolio Management LLC (4.58%).
How many institutions own Edwards Lifesciences stock?
1,387 institutional holdings reports listed Edwards Lifesciences shares in Q2 2026 worth $48.20 billion.
Are Edwards Lifesciences insiders buying or selling the stock?
In the last two years insiders reported 30 sales and no purchases (100 transactions in all); the newest on file is from May 12, 2026.
